“Boring is back for now,” as the “market has gotten defensive,” Jay Woods, chief global strategist at Freedom Capital Market, ...

Ieq Capital LLC boosted its stake in shares of SPDR Portfolio S&P 500 ETF (NYSEARCA:SPLG – Free Report) by 6.5% in the fourth ...

Private Advisor Group LLC boosted its position in shares of Franklin Dynamic Municipal Bond ETF (NYSEARCA:FLMI – Free Report) ...

Despite a 4.4% dividend yield and 154% total return since inception, DLS is rated a Hold due to a lack of compelling ...

Day SEC Yield of 7.04% as of Feb 25. Payable Feb 28; for shareholders of record Feb 24; ex-div Feb 24. More on Invesco Exchange-Traded Fund Trust II - Invesco Global Short Term High Yield Bond ETF ...

Day SEC Yield of 6.95% as of Feb 25. Payable Feb 28; for shareholders of record Feb 24; ex-div Feb 24. More on Invesco Emerging Markets Sovereign Debt Portfolio ETF Seeking Alpha’s Quant Rating on ...

The NYSE Arca filing details how the SEC could allow Grayscale's Ethereum funds to earn staking rewards while maintaining ...

The SEC reviews Grayscale Ethereum ETF's staking proposal, with a decision expected by May 26, potentially impacting staking ...

Highlights,Principal Securities Inc. increased its position in Vanguard S&P 500 Growth ETF by 13.5% in the fourth quarter, ...

The SEC's review of Grayscale's proposal to allow staking in its Ethereum ETFs represents a potential turning point for how ...

The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.